✦ LIBER ✦

Monoamine Oxidase B Inhibitors for the Treatment of Parkinson’s Disease

✍ Scribed by A. H. Schapira

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1-N-Substituted thiocarbamoyl-3-phenyl-5

✍ Gulberk Ucar; Nesrin Gokhan; Akgul Yesilada; A. Altan Bilgin 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 135 KB

Long-term effectiveness of dopamine agon

✍ PD MED Collaborative Group, 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 593 KB

Monoamine oxidase-B (MAO-B) inhibitors:

✍ Teo, Kay; Ho, Shu-Leong 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 263 KB

Monoamine Oxidase-B Inhibition in the Tr

✍ Dr. Hubert H. Fernandez; Dr. Jack J. Chen 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 147 KB

Monoamine oxidase B and Parkinson's dise

✍ Steventon, G; Humfrey, C; Sturman, S; Waring, R.H; Williams, A.C 📂 Article 📅 1990 🏛 The Lancet 🌐 English ⚖ 162 KB

Neuroprotection by monoamine oxidase B i

✍ Rinat Tabakman; Shimon Lecht; Philip Lazarovici 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB